| Effectiveness of digitoxin versus trichlormethiazide/amiloride in congestive heart failure NYHA class II/III and sinus rhythm. | |
| | |
MedLine Citation:
|
PMID: 10439886 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The effects of digitoxin and/or diuretic agents were investigated in patients with congestive heart failure (CHF) in sinus rhythm with respect to changes in hemodynamic parameters, cardiac dimensions, and bicycle ergometric exercise capacity. In a randomized, double-blind study 16 male patients with CHF NYHA class II and III received a placebo for 1 week (baseline) and then were randomly allocated, double blind, to take either digitoxin (digitalis group, DI: N = 8) or trichlormethiazide/amiloride (diuretic group, DG: N = 8) for 3 weeks (VP I). The patients who were first treated with digitoxin received the diuretic agent for a further 3 weeks and vice versa (VP II). At baseline and after VP I and II, a physical examination, two-dimensional echocardiography, and bicycle ergometry were performed. Heart rate (HR), systolic (BPs), and diastolic (BPd) blood pressure at rest, and BPs and 50 watts, were not significantly changed during the observation period. HR at 50 watts was decreased in DI (11.5 +/- 10.1 beats/min.) after VP I and II, but not in DG. BPd was significantly reduced after VP II in DI (8.2 +/- 4.6 mmHg) and in DG (9.3 +/- 8.9 mmHg). DI presents at baseline significantly higher end-diastolic (LVEDV) and end-systolic (LVESV) left ventricular dimensions, whereas left atrial diameter (LA) and stroke volume (SV) and ejection fraction (LVEF) were not significantly different. After VP I, a significantly decreased LA was found in DI, but not in DG. After VP II, all cardiac dimensions were significantly reduced compared with the baseline in DI, whereas in DG only a decrease in LVESV was found. SV was significantly increased in DI, but not in DG after VP I, SV and LVEF were significantly improved in DI and in DG after VP II. Exercise capacity did not change significantly in DI and DG. Digitoxin in combination with trichlormethiazide/amiloride is effective in reducing primarily enlarged left atrial and left ventricular dimensions, and is sufficient to improve the impaired systolic left ventricular function in CHF of NYHA class II and III in sinus rhythm. However, a significant increase in exercise capacity was not found. Treatment with digitoxin seems to be more relevant as a monotherapy with trichlormethiazide/amiloride. |
| | |
Authors:
|
M Huonker; S Sorichter; A Schmidt-Trucksäss; M Irmer; J Staiger; J Keul |
Related Documents
:
|
16449866 - Effects of exercise rehabilitation program on heart rate recovery in patients with chro... 10426836 - Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart ... 11868046 - Ventilatory response to exercise improves risk stratification in patients with chronic ... 11283426 - Exercise training in heart failure: recommendations based on current research. 6471676 - Feasibility and benefits of exercise training in patients on maintenance dialysis. 11726266 - Effect of overhydration on time-trial swim performance. |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy Volume: 13 ISSN: 0920-3206 ISO Abbreviation: Cardiovasc Drugs Ther Publication Date: 1999 May |
Date Detail:
|
Created Date: 1999-09-23 Completed Date: 1999-09-23 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8712220 Medline TA: Cardiovasc Drugs Ther Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 233-41 Citation Subset: IM |
Affiliation:
|
Center for Internal Medicine, University of Freiburg, Germany. honki@msml.ukl.uni-freiburg.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Amiloride / therapeutic use* Anti-Arrhythmia Agents / therapeutic use* Blood Pressure / drug effects Digitoxin / therapeutic use* Diuretics / therapeutic use* Double-Blind Method Drug Combinations Drug Therapy, Combination Exercise Test Heart Failure / classification, drug therapy*, physiopathology* Heart Rate / drug effects Heart Ventricles / anatomy & histology, drug effects Humans Male Middle Aged Placebos Stroke Volume / drug effects Trichlormethiazide / therapeutic use* Ventricular Function, Left / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Arrhythmia Agents; 0/Diuretics; 0/Drug Combinations; 0/Placebos; 133-67-5/Trichlormethiazide; 138258-83-0/Esmalorid; 2609-46-3/Amiloride; 71-63-6/Digitoxin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Enhanced protection of heat shock in myocardial infarction: inhibition of detrimental effect of syst...
Next Document: Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives.